Comment on Seattle biopharma startup lands $19.3M in venture funding for cancer research

Seattle biopharma startup lands $19.3M in venture funding for cancer research

Seattle-based biotechnology company VentiRx revealed it has raised $19.3 million in financing in an SEC filing this week. The company has raised a total of $50 million since opening this round of financing in 2010. The company focuses on developing immunotherapies for the treatment of cancer and inflammatory diseases. Frazier Healthcare Ventures, Arch Venture Partners, Domain Associates, MedImmune Ventures and Celgene Corp.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News